Tigecycline
- Product NDC
- 60505-6098
- 11-digit product format
- 605056098
- Labeler code
- 60505
- Product ID
- 60505-6098_d4e75cae-c197-e995-7903-2d41c6c1371d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- TIGECYCLINE
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Apotex Corp
- Application
- ANDA204439
- Marketing category
- ANDA
- Marketing start
- 2019-04-09
- Substance
- TIGECYCLINE
- Active strength
- 50 mg/5mL
- Pharmacologic classes
- Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tigecycline
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TIGECYCLINE | 50 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 70JE2N95KR |
| Rxcui | 581531 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60505-6098-1 | Tigecycline | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | | 12 |
| 60505-6098-1 | Tigecycline | 5 mL in 1 VIAL, SINGLE-USE | INJECTION, POWDER, LYOPHILIZED, | 5 | | 12 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60505-6098 | TIGECYCLINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APOTEX CORP] | 11 | Current NDC, Legacy NDC, 2 package rows | 20250507_230484a8-408c-dcc1-d0c4-d9dd9a46831b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60505-6098-1 | 60505609801 | 10 VIAL, SINGLE-USE in 1 CARTON (60505-6098-1) / 5 mL in 1 VIAL, SINGLE-USE | 2019-04-09 | 0000-00-00 | No | No | Current |